NCT05158868 is a clinical trial of HiF-1 alpha measurement in Hif-1α Covid-19, sponsored by Assiut University.

Who is sponsoring NCT05158868?

NCT05158868 is sponsored by Assiut University.

What drugs are being tested in NCT05158868?

Interventions in NCT05158868: HiF-1 alpha measurement.

What condition does NCT05158868 study?

NCT05158868 studies Hif-1α Covid-19.

Is NCT05158868 still recruiting?

NCT05158868 is currently status unknown. Last updated 15 December 2021.

Last reviewed 2021-12-15 · How we verify

NCT05158868

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.

Status unknown Last updated 15 December 2021

What this trial tests

trial testing HiF-1 alpha measurement in Hif-1α Covid-19 in 50 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
30 September 2022

30 June 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 January 2022
Primary completion	30 September 2022
Estimated completion	30 June 2023

Drugs / interventions tested

HiF-1 alpha measurement

Conditions studied

Hif-1α Covid-19 — all drugs for Hif-1α Covid-19 →

Sponsor

Assiut University

Who can join

Adults 18 to 40, female only, with Hif-1α Covid-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the risk of hypoxia in placenta of normal pregnant women infected with covid-19 during third trimester of pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05158868 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 15 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05158868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing